KLP Kapitalforvaltning’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,700
Closed -$82.8K 2175
2025
Q4
$82.8K Hold
20,700
﹤0.01% 2113
2025
Q3
$175K Hold
20,700
﹤0.01% 1873
2025
Q2
$233K Hold
20,700
﹤0.01% 1719
2025
Q1
$196K Hold
20,700
﹤0.01% 1754
2024
Q4
$233K Buy
+20,700
New +$364K ﹤0.01% 1757

Other funds holding EVH

KLP Kapitalforvaltning's EVH Position: Q1 2026 in Review

KLP Kapitalforvaltning sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 20,700 shares — an estimated $82.8K sold.

KLP Kapitalforvaltning first reported a position in EVH in Q4 2024 and held it in 5 quarters. The position peaked at $233K in Q2 2025. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • KLP Kapitalforvaltning reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • KLP Kapitalforvaltning sold 20,700 Evolent Health shares in Q1 2026, an estimated $82.8K.
  • KLP Kapitalforvaltning first reported a position in Evolent Health in Q4 2024 and held it in 5 quarters.
  • KLP Kapitalforvaltning's Evolent Health position peaked at $233K in Q2 2025.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.